Filters
In the treatment of individuals with cocaine use disorder, the use of psilocybin may help improve abstinence rates and reduce the risk of cocaine lapse over time, as shown in a study.
Daily treatment with oral orforglipron, when added to titrated insulin glargine, has been shown to be beneficial in individuals with inadequately controlled type 2 diabetes (T2D) in the phase 3 ACHIEVE-5 trial.
Treatment with tirzepatide yields robust reductions in HbA1c, weight, and waist circumference in patients with early type 2 diabetes (T2D) uncontrolled with metformin, reports a study.
Vaccination against COVID-19 provides survival benefits to cancer patients receiving immune checkpoint inhibitors (ICIs), as shown in a recent study.
In healthy females, the change in supine-to-standing systolic blood pressure (SBP) is associated with mortality, regardless of traditional risk factors and antihypertensive medications, suggests a study.
Findings from the phase III RESILIENT study show that a sublingual formulation of cyclobenzaprine (CBP SL) may benefit individuals with fibromyalgia.
In the treatment of patients with resected non–small cell lung cancer (NSCLC) without sensitizing EGFR and ALK alterations, adjuvant nivolumab does not appear to yield improvements in disease-free survival (DFS) when given after planned adjuvant chemotherapy and/or radiotherapy, according to a phase 3 study.
In a network meta-analysis of discontinuation of blood-pressure (BP)-lowering medications due to adverse effects (AEs), the best-tolerated treatment was a combination of an angiotensin receptor blocker (ARB) and a calcium channel blocker (CCB), with four of the top five best-tolerated regimens containing ARBs.
Antibiotic resistance genes (ARGs)—DNA segments that enable bacterial survival in the presence of antibiotics— can be detected in newborns’ meconium shortly after birth, as shown in a study presented at ESCMID Global 2026.
The investigational ileal bile acid transporter (IBAT) inhibitor volixibat provides rapid and sustained improvement in pruritus in patients with primary sclerosing cholangitis, according to the topline results of the VISTAS study.
